共 173 条
[1]
Robert C(2020)A decade of immune-checkpoint inhibitors in cancer therapy Nat Commun 11 3801-1014
[2]
Khair DO(2019)Combining immune checkpoint inhibitors: established and emerging targets and strategies to improve outcomes in melanoma Front Immunol 10 453-670
[3]
Bax HJ(2021)Immune checkpoint inhibitors in melanoma Lancet 398 1002-1189
[4]
Mele S(2022)A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance Nat Immunol 23 660-538
[5]
Carlino MS(2019)5-year results for pembrolizumab treatment of advanced melanoma Lancet Oncol 20 1187-396
[6]
Larkin J(2015)Cancer and the Immune System: Basic Concepts and Targets for Intervention Semin Oncol 42 523-264
[7]
Long GV(2019)Novel patterns of response under immunotherapy Ann Oncol 30 385-448
[8]
Huang AC(2022)18F FDG PET/CT and Novel Molecular Imaging for Directing Immunotherapy in Cancer Radiology 304 246-1428
[9]
Zappasodi R(2019)Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors J Immunother Cancer 7 306-383
[10]
Hassel JC(2020)Are immune-related adverse events associated with the efficacy of immune checkpoint inhibitors in patients with cancer? A systematic review and meta-analysis BMC Med 18 87-341